Literature DB >> 25281324

Biphasic modulation of paracellular claudin-5 expression in mouse brain endothelial cells is mediated through the phosphoinositide-3-kinase/AKT pathway.

Ryan B Camire1, Holly J Beaulac1, Stephanie A Brule1, Annie I McGregor1, Emily E Lauria1, Colin L Willis2.   

Abstract

Blood-brain barrier (BBB) integrity is compromised in many central nervous system disorders. Complex astrocyte and vascular endothelial cell interactions that regulate BBB integrity may be disturbed in these disorders. We previously showed that systemic administration of 3-chloropropanediol [(S)-(+)-3-chloro-1,2-propanediol] induces a transitory glial fibrillary acidic protein-astrocyte loss, reversible loss of tight junction complexes, and BBB integrity disruption. However, the intracellular signaling mechanisms that induce BBB integrity marker loss are unclear. We hypothesize that 3-chloropropanediol-induced modulation of tight junction protein expression is mediated through the phosphoinositide-3-kinase (PI3K)/AKT pathway. To test this hypothesis, we used a mouse brain endothelial cell line (bEnd.3) exposed to 3-chloropropanediol for up to 3 days. Results showed early reversible loss of sharp paracellular claudin-5 expression 90, 105, and 120 minutes after 3-chloropropanediol (500 μM) treatment. Sharp paracellular claudin-5 profiles were later restored, but lost again by 2 and 3 days after 3-chloropropanediol treatment. Western blot and immunofluorescence studies showed increased p85-PI3K expression and transitory increased AKT (Thr308) phosphorylation at 15 and 30 minutes after 3-chloropropanediol administration. PI3K inhibitors LY294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one hydrochloride; 2.5-25 μM] and PI-828 [2-(4-morpholinyl)-8-(4-aminopheny)l-4H-1-benzopyran-4-one; 0.1-10 μM] prevented the 3-chloropropanediol-induced AKT (Thr308) phosphorylation and both early and late loss of paracellular claudin-5. However, AKT inhibitors only prevented the early changes in claudin-5 expression. This mechanistic study provides a greater understanding of the intracellular signaling pathways mediating tight junction protein expression and supports a hypothesis that two independent pathways triggered by PI3K mediate early and late loss of paracellular claudin-5 expression.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25281324      PMCID: PMC4244583          DOI: 10.1124/jpet.114.218339

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  40 in total

Review 1.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

2.  Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells.

Authors:  Rachel C Brown; Andrew P Morris; Roger G O'Neil
Journal:  Brain Res       Date:  2006-12-12       Impact factor: 3.252

Review 3.  Transmembrane proteins of tight junctions.

Authors:  Hideki Chiba; Makoto Osanai; Masaki Murata; Takashi Kojima; Norimasa Sawada
Journal:  Biochim Biophys Acta       Date:  2007-09-04

4.  Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation.

Authors:  Melissa A Fleegal; Sharon Hom; Lindsay K Borg; Thomas P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-01       Impact factor: 4.733

5.  Phorbol ester induced short- and long-term permeabilization of the blood-CSF barrier in vitro.

Authors:  Susanne Angelow; Patrick Zeni; Britta Höhn; Hans-Joachim Galla
Journal:  Brain Res       Date:  2005-11-03       Impact factor: 3.252

6.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Authors:  D R Alessi; S R James; C P Downes; A B Holmes; P R Gaffney; C B Reese; P Cohen
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

7.  Identification of isoforms of G proteins and PKC that colocalize with tight junctions.

Authors:  V Dodane; B Kachar
Journal:  J Membr Biol       Date:  1996-02       Impact factor: 1.843

8.  Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat.

Authors:  Ken A Witt; Karen S Mark; Karin E Sandoval; Thomas P Davis
Journal:  Microvasc Res       Date:  2007-06-26       Impact factor: 3.514

9.  Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling.

Authors:  Gerty Schreibelt; Gijs Kooij; Arie Reijerkerk; Ruben van Doorn; Sonja I Gringhuis; Susanne van der Pol; Babette B Weksler; Ignacio A Romero; Pierre-Olivier Couraud; Jörg Piontek; Ingolf E Blasig; Christine D Dijkstra; Eric Ronken; Helga E de Vries
Journal:  FASEB J       Date:  2007-06-22       Impact factor: 5.191

10.  The selective neurotoxicity produced by 3-chloropropanediol in the rat is not a result of energy deprivation.

Authors:  J Skamarauskas; W Carter; M Fowler; A Madjd; T Lister; G Mavroudis; D E Ray
Journal:  Toxicology       Date:  2007-01-21       Impact factor: 4.221

View more
  13 in total

1.  Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.

Authors:  Zhen Li; Xiao-Bai Liu; Yun-Hui Liu; Yi-Xue Xue; Jing Liu; Hao Teng; Zhuo Xi; Yi-Long Yao
Journal:  J Mol Neurosci       Date:  2015-10-31       Impact factor: 3.444

Review 2.  Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.

Authors:  Shuwen Deng; Hui Liu; Ke Qiu; Hong You; Qiang Lei; Wei Lu
Journal:  Mol Neurobiol       Date:  2017-07-20       Impact factor: 5.590

3.  Acid fibroblast growth factor preserves blood-brain barrier integrity by activating the PI3K-Akt-Rac1 pathway and inhibiting RhoA following traumatic brain injury.

Authors:  Fenzan Wu; Zaifeng Chen; Chonghui Tang; Jinjing Zhang; Li Cheng; Hongxia Zuo; Hongyu Zhang; Daqing Chen; Liping Xiang; Jian Xiao; Xiaokun Li; Xinlong Xu; Xiaojie Wei
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 4.  Junctional proteins of the blood-brain barrier: New insights into function and dysfunction.

Authors:  Svetlana M Stamatovic; Allison M Johnson; Richard F Keep; Anuska V Andjelkovic
Journal:  Tissue Barriers       Date:  2016-02-26

Review 5.  Systems Proteomics View of the Endogenous Human Claudin Protein Family.

Authors:  Fei Liu; Michael Koval; Shoba Ranganathan; Susan Fanayan; William S Hancock; Emma K Lundberg; Ronald C Beavis; Lydie Lane; Paula Duek; Leon McQuade; Neil L Kelleher; Mark S Baker
Journal:  J Proteome Res       Date:  2016-01-12       Impact factor: 4.466

6.  Transitory loss of glia and the subsequent modulation in inflammatory cytokines/chemokines regulate paracellular claudin-5 expression in endothelial cells.

Authors:  Ryan B Camire; Holly J Beaulac; Colin L Willis
Journal:  J Neuroimmunol       Date:  2015-05-13       Impact factor: 3.478

7.  Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Secreted by BMSCs Regulates Activated Astrocytes by Inhibiting NF-κB Signaling Pathway to Ameliorate Blood Brain Barrier Damage After Intracerebral Hemorrhage.

Authors:  Bin Tang; Min Song; Xun Xie; Dongsheng Le; Qiulin Tu; Xiang Wu; Min Chen
Journal:  Neurochem Res       Date:  2021-06-19       Impact factor: 3.996

8.  Glycolysis and oxidative phosphorylation are essential for purinergic receptor-mediated angiogenic responses in vasa vasorum endothelial cells.

Authors:  Martin Lapel; Philip Weston; Derek Strassheim; Vijaya Karoor; Nana Burns; Taras Lyubchenko; Petr Paucek; Kurt R Stenmark; Evgenia V Gerasimovskaya
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-16       Impact factor: 4.249

9.  Picroside II protects the blood-brain barrier by inhibiting the oxidative signaling pathway in cerebral ischemia-reperfusion injury.

Authors:  Li Zhai; Min Liu; Tingting Wang; Hongyan Zhang; Shan Li; Yunliang Guo
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

10.  Epidermal growth factor attenuates blood-spinal cord barrier disruption via PI3K/Akt/Rac1 pathway after acute spinal cord injury.

Authors:  Binbin Zheng; Libing Ye; Yulong Zhou; Sipin Zhu; Qingqing Wang; Hongxue Shi; Daqing Chen; Xiaojie Wei; Zhouguang Wang; Xiaokun Li; Jian Xiao; Huazi Xu; Hongyu Zhang
Journal:  J Cell Mol Med       Date:  2016-01-15       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.